BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Bleomycin
,
rs7903146
,
IGF1
,
Angiogenesis
,
Breast Cancer
,
Kidney
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
interferon alfacon- 1
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Evaluating the ion exchange chromatography for matrix-assisted PEGylation and purification of consen…
Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treat…
Optimization of conditions for high-level expression and purification of human recombinant consensus…
Human consensus interferons: Bridging the natural and artificial cytokines with intrinsic disorder.
Pharmacokinetics, tissue distribution, excretion, and antiviral activity of pegylated recombinant hu…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Rib…
Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial
Observational Prospective Registry of the Efficacy, Safety, and Adherence to Infergen® in Patients I…
Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy
Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ